CXCL8 and in situ carcinoma: Serum concentrations of measured cytokines are shown in Additional file 1: Figure S1; significant changes were only observed for CCL3, CXCL8, and IL6 with significantly lower concentrations in patients with CIS-RRMS when compared to patients with NIND.